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ly resected. No intrapulmonary lesion was detected.
Macroscopically, the resected tumor was solid, gray-white, and
encapsulated (5 × 3.5 × 3 cm, 75 g). Microscopically, the tumor
was composed of atypical small spindle cells showing dense
proliferation, and it was pathologically diagnosed as small cell
carcinoma. No pathologic findings were obtained to specify the
origin of the carcinoma. The postoperative course was unevent-
ful, and oral prednisolone was continued. The patient’s muscle
strength gradually improved, and his grip was 35 kg at 20 days
after the operation. He was discharged after prophylactic adju-
vant chemoradiotherapy. The value of serum NSE and progas-
trin-releasing peptide decreased to 8.0 ng/mL and 17.4 pg/mL
6 months after the operation. They remained at normal levels
thereafter. The titer of serum anti–P/Q-type voltage-gated calci-
um channel antibodies (VGCCAs) was 479.1 pmol/L at 1
month and 72.6 pmol/L at 22 months after the operation. The
patient is alive without recurrence at 24 months, and his muscle
strength has completely recovered.
Discussion. LEMS is known to be often associated with
SCLC and sometimes with other malignant diseases.
However, to our knowledge, this is the first case of LEMS
combined with an anterior mediastinal small cell carcinoma.
Extrapulmonary small cell carcinoma (EPSCC) is rare,
and the overall 5-year survival was reported to be 13% in a
recent study.2 However, a patient with mediastinal EPSCC
who underwent complete tumor resection with adjuvant
therapy has been reported.3 Although the tumor origin in the
present case was not specified, the possible origin may be
lymph nodes or ectopic thymus. According to a review by
Galanis and colleagues2 of 81 patients with EPSCC, 5 origi-
Approximately 60% of patients with Lambert-Eaton myas-
thenic syndrome (LEMS) have small cell lung carcinoma
(SCLC).1 However, LEMS is infrequently associated with
carcinomas in other sites. We present here a rare case of
LEMS with an anterior mediastinal small cell carcinoma in a
patient who had no pulmonary lesion detected.
Clinical summary. A 46-year-old man was admitted to a
local hospital because of fatigability, muscle weakness of the
extremities, and double vision. On the basis of a tentative
diagnosis of chronic inflammatory demyelinating polyradicu-
loneuropathy, he was treated with oral prednisolone (15 mg
every other day) and 8 sessions of plasmapheresis; however,
the symptoms were only temporarily relieved. Six months
later, he was referred to us. On examination, bilateral ptosis,
facial and bulbar paresis, proximal-dominant limb muscle
atrophy, and generalized areflexia were observed. His grip
was 20 kg at most. No lymph node was palpable in the
patient’s neck or axillae. Electrodiagnostic study demonstrat-
ed abnormally low-amplitude compound muscle action poten-
tials and a remarkable waxing after repetitive stimulation at
50 Hz. The serum antibodies to a subtype of voltage-gated
calcium channels (VGCCs), P/Q type VGCCs, markedly
increased to 432.9 pmol/L (normally <20.0 pmol/L). These
findings were consistent with a diagnosis of LEMS, and
screening for malignant diseases was performed. Chest radi-
ography and computed tomography (CT) revealed a solid
mass on the left side of the aortic arch (Fig 1). No abnormal
findings were noted in the bilateral lung fields. Broncho-
fiberoscopy also showed no abnormalities. The serum neuron-
specific enolase (NSE) and progastrin-releasing peptide were
elevated to 17.1 ng/mL and 121.4 pg/mL (normally <10.0
ng/mL and 46.0 pg/mL), respectively. No metastasis was
observed with brain CT, abdominal CT, or bone scintigraphy.
Through a median sternotomy, an encapsulated tumor was
found on the left anterior side of the aortic arch. The tumor was
adjacent to the left lobe of the thymus and did not invade sur-
rounding structures. The tumor and the thymus were complete-
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Fig 1. CT demonstrating a mass on the left side of the aortic
arch.
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nated from lymph nodes and 3 from thymus. Of course, we
cannot completely exclude the possibility that the tumor was
a metastasis to mediastinal lymph nodes from invisible
SCLC.
LEMS is an autoimmune disorder of peripheral cholinergic
synapses caused by abnormal anti-VGCCAs, which inhibit
the regular calcium influx through VGCCs in nerve endings.4
Recently, Motomura and colleagues5 have suggested that
anti–P/Q-type VGCCAs may play a central role in the patho-
genesis of LEMS. In the present case the serum anti–P/Q-
type VGCCAs were markedly elevated before the operation.
The titer of the antibodies remained high for at least 1 month
and decreased 24 months after the operation, whereas the
patient’s muscle strength began to recover as early as 2 weeks
after the operation. These findings suggest some discrepancy
between the improvement of symptoms and the titer of
anti–P/Q type-VGCCAs. Anti–P/Q-type VGCCAs show
polyclonal and heterogeneous properties in its immunoreac-
tivity. This heterogeneity would be consistent with the poor
correlation between antibody titer and clinical severity.
Further studies are necessary to elucidate the pathophysio-
logic role of the antibodies in LEMS.
